Do you want to learn more about the RECOVER Long COVID study? Please join this special event.

Friday, January 10, 2025

Providence Swedish is participating in the RECOVER-VITAL trial, a first-of-its-kind Long COVID study that is helping experts understand the effectiveness of long COVID treatments. Join us on Jan. 15 for a special virtual event to learn more.

Since November 2023, Providence Swedish infectious disease experts have been participating in the RECOVER-VITAL clinical trial which is studying whether Paxlovid, an antiviral drug used to treat mild-to-moderate COVID infections, can be used to treat the symptoms of Long COVID. 

The RECOVER-VITAL study is the largest clinical trial to date of Long COVID, and part of a larger group of studies within RECOVER (Researching COVID to Enhance Recovery) seeking to find treatments for Long COVID. Swedish is among the dozens of U.S. trial sites that have enrolled patients into this important research. 

We invite you to join us on Wednesday, Jan. 15 from 6 to 7 p.m. PST for a virtual event where you can learn more about the study’s progress and plans for RECOVER 2.0, including RECOVER Treating Long COVID (TLC). You’ll also have the opportunity to participate in a Q&A with a panel of RECOVER’s coordinators and research leaders. Please use this link to register.  

About Providence Swedish 

Providence Swedish has served the Puget Sound region since the first Providence hospital opened in Seattle in 1877 and the first Swedish hospital opened in 1910. The two organizations affiliated in 2012 and today comprise the largest health care delivery system in Western Washington, with 22,000 caregivers, eight hospitals and 244 clinics throughout Western Washington – from Everett to Centralia. A not-for-profit family of organizations, Providence Swedish provides more than $545 million in community benefit in the Puget Sound region each year. The health system offers a comprehensive range of services and specialty and subspecialty care in a number of clinical areas, including cancer, cardiovascular health, neurosciences, orthopedics, digestive health and women’s and children’s care. For more information, visit providence.org/swedish. 

 

Do you want to learn more about the RECOVER Long COVID study? Please join this special event.
1/10/2025
Providence Swedish has been participating in the RECOVER study, a first-of-its-kind trial studying Long COVID treatments. We invite you to join us on Jan. 15 for a special virtual event to learn more.
Evan Ong, M.D., named Doctor of the Year by Puget Sound Business Journal
12/19/2024
He led the way in helping Swedish’s First Hill campus become the first hospital on the West Coast to begin offering a new treatment called histotripsy.
Providence Swedish hospitals named among nation’s best for maternity care
12/10/2024
Providence Swedish delivers more babies each year than any hospital system in Western Washington and we have been consistently recognized for excellence in maternity care.
Dr. Ashwani Rajput shares his vision for the Providence Swedish Cancer Institute
12/5/2024
Newly appointed Regional Executive Medical Director for Providence Swedish Cancer Institute Dr. Ashwani Rajput works to continue building on the institute’s excellence in cancer care.